Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
Dr. Wegrzyn will talk about the role of the Advanced Research Projects Agency for Health (ARPA-H) in supporting innovative science, with time to ask questions. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)!
ASGCT is excited to announce that Dr. Renee Wegrzyn, Director of the Advanced Research Projects Agency for Health (ARPA-H), will join this year’s Policy Summit in a fireside chat titled "How ARPA-H Supports Biomedical Innovation."
Dr. Wegrzyn’s session will launch Day 2 of the conference on Sept. 19. Tune in to hear how ARPA-H advances high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional channels—and supports CGT development. Policy Summit attendees will also have the opportunity to ask questions of the Director.
After the fireside chat, stick around for other regulatory-focused sessions on standards for CGTs, manufacturing policy realities, patient-centered clinical development, and more!
ASGCT's Policy Summit connects you with policy and industry leaders in the field where you'll learn from a variety of stakeholder perspectives and how they inform regulatory, legislative, and payment policies that impact gene and cell therapy development. Join us virtually or in person!
In-person registration will be extremely limited - so register today to secure your spot in Washington, DC!
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico